Therapeutic strategies for multiple sclerosis: Current data
Journal
International Journal of Health & Allied Sciences
Date Issued
March 2015
Author(s)
DOI
10.4103/2278-344X.149199
Abstract
At present, the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved drugs for Relapsing Remitting Multiple Sclerosis (RRMS) and Secondary Progressive MS (SPMS). In this paper, modern therapeutic strategies for MS are reviewed. A comprehensive research in MEDLINE, PUBMED, and SCIENCEDIRECT databases using two Boolean phrases {i.e. 1. [(Multiple Sclerosis) and (Disease Modifying Therapies)] and 2. [(Multiple Sclerosis) and (Neuroprotective Therapies)]} yielded more than 1,5000 articles in total. Therefore, for the purposes of
this paper, articles written within the last decade were considered for review.
this paper, articles written within the last decade were considered for review.
File(s)![Thumbnail Image]()
Name
IntJHealthAlliedSci413-1951091_052510.pdf
Size
558.31 KB
Format
Adobe PDF
Checksum (MD5)
5f9ca0728191e94ad58edadaae0a9dfd